These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 8489326)

  • 21. Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study.
    Loew TH; Nickel MK; Muehlbacher M; Kaplan P; Nickel C; Kettler C; Fartacek R; Lahmann C; Buschmann W; Tritt K; Bachler E; Mitterlehner F; Pedrosa Gil F; Leiberich P; Rother WK; Egger C
    J Clin Psychopharmacol; 2006 Feb; 26(1):61-6. PubMed ID: 16415708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.
    Schulz SC; Camlin KL; Berry SA; Jesberger JA
    Biol Psychiatry; 1999 Nov; 46(10):1429-35. PubMed ID: 10578457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between borderline personality disorder and Axis I diagnosis in severity of depression and anxiety.
    Comtois KA; Cowley DS; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1999 Nov; 60(11):752-8. PubMed ID: 10584763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-ratings of anger and hostility in borderline personality disorder.
    Gardner DL; Leibenluft E; O'Leary KM; Cowdry RW
    J Nerv Ment Dis; 1991 Mar; 179(3):157-61. PubMed ID: 1997664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depressive experiences in inpatients with borderline personality disorder.
    Levy KN; Edell WS; McGlashan TH
    Psychiatr Q; 2007 Jun; 78(2):129-43. PubMed ID: 17347875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A preliminary trial of fluoxetine in refractory borderline patients.
    Cornelius JR; Soloff PH; Perel JM; Ulrich RF
    J Clin Psychopharmacol; 1991 Apr; 11(2):116-20. PubMed ID: 2056138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study.
    Zanarini MC; Schulz SC; Detke HC; Tanaka Y; Zhao F; Lin D; Deberdt W; Kryzhanovskaya L; Corya S
    J Clin Psychiatry; 2011 Oct; 72(10):1353-62. PubMed ID: 21535995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizing depression in borderline patients.
    Soloff PH; George A; Nathan RS; Schulz PM
    J Clin Psychiatry; 1987 Apr; 48(4):155-7. PubMed ID: 3558327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interrelationship of hysteroid dysphoria and borderline personality disorder.
    Liebowitz MR; Klein DF
    Psychiatr Clin North Am; 1981 Apr; 4(1):67-87. PubMed ID: 7232238
    [No Abstract]   [Full Text] [Related]  

  • 30. A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives.
    Rothschild R; Quitkin HM; Quitkin FM; Stewart JW; Ocepek-Welikson K; McGrath PJ; Tricamo E
    Int J Eat Disord; 1994 Jan; 15(1):1-9. PubMed ID: 8124322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing impulsiveness, hostility, and depression in borderline personality disorder and bipolar II disorder.
    Wilson ST; Stanley B; Oquendo MA; Goldberg P; Zalsman G; Mann JJ
    J Clin Psychiatry; 2007 Oct; 68(10):1533-9. PubMed ID: 17960968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open trial of valproate in borderline personality disorder.
    Stein DJ; Simeon D; Frenkel M; Islam MN; Hollander E
    J Clin Psychiatry; 1995 Nov; 56(11):506-10. PubMed ID: 7592502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder.
    Blanco C; Heimberg RG; Schneier FR; Fresco DM; Chen H; Turk CL; Vermes D; Erwin BA; Schmidt AB; Juster HR; Campeas R; Liebowitz MR
    Arch Gen Psychiatry; 2010 Mar; 67(3):286-95. PubMed ID: 20194829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
    Paykel ES; Rowan PR; Parker RR; Bhat AV
    Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients.
    Linehan MM; Heard HL; Armstrong HE
    Arch Gen Psychiatry; 1993 Dec; 50(12):971-4. PubMed ID: 8250683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenelzine vs atenolol in social phobia. A placebo-controlled comparison.
    Liebowitz MR; Schneier F; Campeas R; Hollander E; Hatterer J; Fyer A; Gorman J; Papp L; Davies S; Gully R
    Arch Gen Psychiatry; 1992 Apr; 49(4):290-300. PubMed ID: 1558463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].
    Chabrol H; Chouicha K; Montovany A; Callahan S
    Encephale; 2001; 27(2):120-7. PubMed ID: 11407263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the suicidal behavior of adolescent inpatients with borderline personality disorder and major depression.
    Horesh N; Orbach I; Gothelf D; Efrati M; Apter A
    J Nerv Ment Dis; 2003 Sep; 191(9):582-8. PubMed ID: 14504567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol.
    Serban G; Siegel S
    Am J Psychiatry; 1984 Nov; 141(11):1455-8. PubMed ID: 6388363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.